Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized Clinical Study to Evaluate the Pharmacokinetics and Safety of BCD-201 (JSC BIOCAD, Russia) and Keytruda® in Patients With Different Advanced Malignancies

NCT05739006 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT05739006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05739006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized Clinical Study to Evaluate the Pharmacokinetics and Safety of BCD-201 (JSC BIOCAD, Russia) and Keytruda® in Patients With Different Advanced Malignancies
Lead sponsor
Biocad
Phase
Phase 1
Overall status
Unknown status
Start date
February 8, 2021
Completion date
August 31, 2023
Enrollment
131 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, non small cell lung cancer